These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2830121)

  • 1. Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord.
    Przewłocki R; Costa T; Lang J; Herz A
    Eur J Pharmacol; 1987 Nov; 144(1):91-5. PubMed ID: 2830121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons.
    Adams DJ; Trequattrini C
    J Neurophysiol; 1998 Feb; 79(2):753-62. PubMed ID: 9463438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin reduces the day-night rhythm of nociception and mu and kappa opioid peptide-mediated antinociception in the snail, Cepaea nemoralis.
    Yu N; Kavaliers M
    Peptides; 1991; 12(4):877-81. PubMed ID: 1664949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
    Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
    Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxin ADP-ribosylates the receptor-coupled form of pertussis toxin-sensitive G-proteins.
    Klinz FJ; Costa T
    Biochem Biophys Res Commun; 1989 Dec; 165(2):554-60. PubMed ID: 2557017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of opiate agonists administered intrathecally on the behavioral and hemodynamic manifestations of pain].
    Zaĭtsev AA; Petriaevskaia NV; Khvan AA
    Farmakol Toksikol; 1988; 51(1):23-5. PubMed ID: 2834219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of various opiate receptors in the regulation of the nociceptive reaction of the arterial pressure].
    Ignatov IuD; Zaĭtsev AA
    Biull Eksp Biol Med; 1987 Apr; 103(4):420-2. PubMed ID: 3032301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
    Passarelli F; Costa T
    J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors.
    Wong CS; Su YF; Chang KJ; Watkins WD
    Anesthesiology; 1992 Oct; 77(4):691-9. PubMed ID: 1329580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis toxin pretreatment antagonizes the actions of mu- and delta-opiate agonists in hippocampal slices.
    Dunwiddie TV; Su MT
    Neurosci Lett; 1988 Dec; 95(1-3):329-34. PubMed ID: 2852323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
    Dray A; Nunan L; Wire W
    J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.